Literature DB >> 20101658

Inadequacies of absolute threshold levels for diagnosing prediabetes.

Michael Bergman1.   

Abstract

Prediabetes comprising Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) represents an intermediate stage of altered glucose metabolism between normal glucose levels and type 2 diabetes mellitus and is associated with an increased risk for the development of diabetes and cardiovascular disease. There is considerable evidence that glucose levels lower than those meeting the current definition of prediabetes may also be associated with similar risks particularly in high-risk individuals. Prediabetes is often unrecognized and therefore constitutes a major public health concern suggesting the need for earlier intervention than is currently recommended. Copyright (c) 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101658     DOI: 10.1002/dmrr.1013

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  14 in total

1.  Reducing the prevalence of dysglycemia: is the time ripe to test the effectiveness of intervention in high-risk individuals with elevated 1 h post-load glucose levels?

Authors:  Michael Bergman; Ram Jagannathan; Martin Buysschaert; Jose Luis Medina; Mary Ann Sevick; Karin Katz; Brenda Dorcely; Jesse Roth; Angela Chetrit; Rachel Dankner
Journal:  Endocrine       Date:  2017-01-25       Impact factor: 3.633

2.  Are current diagnostic guidelines delaying early detection of dysglycemic states? Time for new approaches.

Authors:  Michael Bergman; Rachel Dankner; Jesse Roth; K M Venkat Narayan
Journal:  Endocrine       Date:  2013-01-17       Impact factor: 3.633

3.  Chronic stress, inflammation, and glucose regulation in U.S. Hispanics from the HCHS/SOL Sociocultural Ancillary Study.

Authors:  Jessica L McCurley; Paul J Mills; Scott C Roesch; Mercedes Carnethon; Rebeca E Giacinto; Carmen R Isasi; Yanping Teng; Daniela Sotres-Alvarez; Maria M Llabre; Frank J Penedo; Neil Schneiderman; Linda C Gallo
Journal:  Psychophysiology       Date:  2015-04-20       Impact factor: 4.016

4.  Inadequacies of current approaches to prediabetes and diabetes prevention.

Authors:  Michael Bergman
Journal:  Endocrine       Date:  2013-07-24       Impact factor: 3.633

5.  BMP-7 attenuates adverse cardiac remodeling mediated through M2 macrophages in prediabetic cardiomyopathy.

Authors:  Princess Urbina; Dinender K Singla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-03       Impact factor: 4.733

6.  Diabetes prevention: global health policy and perspectives from the ground.

Authors:  Michael Bergman; Martin Buysschaert; Peter Eh Schwarz; Ann Albright; Km Venkat Narayan; Derek Yach
Journal:  Diabetes Manag (Lond)       Date:  2012

Review 7.  Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus.

Authors:  Michael Bergman
Journal:  Endocrine       Date:  2012-11-07       Impact factor: 3.633

8.  Does elevated plasma triglyceride level independently predict impaired fasting glucose?: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Susan X Lin; Ivan Berlin; Richard Younge; Zhezhen Jin; Christopher T Sibley; Pamela Schreiner; Moyses Szklo; Alain G Bertoni
Journal:  Diabetes Care       Date:  2012-10-01       Impact factor: 19.112

9.  Hair follicle characteristics as early marker of Type 2 Diabetes.

Authors:  J Jaime Miranda; Alvaro Taype-Rondan; Jose Carlos Tapia; Maria Gabriela Gastanadui-Gonzalez; Ricardo Roman-Carpio
Journal:  Med Hypotheses       Date:  2016-08-16       Impact factor: 4.411

10.  High prevalence of dyslipidemia and associated risk factors among rural Chinese adults.

Authors:  Guo-Zhe Sun; Zhao Li; Liang Guo; Ying Zhou; Hong-Mei Yang; Ying-Xian Sun
Journal:  Lipids Health Dis       Date:  2014-12-12       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.